O Hui

While much of prestige Korean beauty was busy excavating hanbang herbal lore and royal-court recipes, this line went looking for credibility in a different place entirely: the cell. The bet was that an affluent shopper who could buy any luxury cream might be persuaded by the language of biology rather than tradition, a name and a story that read like a lab notebook instead of a poem. It made the brand the conspicuous science geek among glossier, more nostalgic siblings under the same corporate roof.

That positioning sharpened over time around plant-derived stem-cell technology, with the house claiming an early-mover role in bringing the concept to Korean cosmeceuticals and partnering with a stem-cell research institute to back its flagship work. The marquee effort, The First line, leans on a recombinant protein and proprietary "complexes" pitched at firming, brightening, and hydration, sold at the very top of the department-store shelf. The textures are genuinely lovely; the price tags assume you find the science narrative as seductive as the slip of the cream.

The brand's fortunes have been inseparable from China. A determined push into Chinese department stores from the mid-2000s, fronted by celebrity ambassadors, turned the line into a serious regional player and international sales soared on Chinese demand. Then the same market that built it forced a retreat: as China's prestige-beauty landscape shifted and counter traffic cooled, the company shuttered offline outlets and pivoted to online channels, a vivid reminder that even conglomerate-backed luxury lives and dies by regional tides. The episode reframed the brand from a counter fixture into a digital-first proposition, the science story now doing its persuading on a phone screen rather than under department-store lighting.

Sources:[1][2]